Core Scientific
- Ticker
- CORZ
- Beat
- datacenters
- Size
- Public Company
- Revenue
- $164M
- as of Jun 2026
- Cash
- $1.8B
- as of Jun 2026
- Burn
- $584M/qtr
- as of Jun 2026
- Runway
- ~3 qtr at this rate
- as of Jun 2026
- Researched · Fresh
- 6 days ago
CORZ swapped a tenant problem for a build-and-finance problem. AMD's 530 MW / $14B+ lease package (377 MW direct plus 152 MW to an AMD-guaranteed neocloud, with a 1.9 GW reservation) means CoreWeave's share of contracted power falls toward ~53%. The price was a 30M-share warrant and ~$6B more project debt on top of $4.4B, with book equity at −$2.4B. At $17.34 (−38% since June) the company trades at about 11x contracted NOI on a fully diluted, fully built enterprise value, a leveraged builder at
2 mentions across our dossiers
“- New competitor names the 10-K now lists: Digital Realty, Equinix, plus IREN, Cipher, TeraWulf, Hut 8, Riot, CleanSpark, HIVE, Core Scientific, Bitdeer, Galaxy Digital, Fermi Inc., Keel Infrastructure, MARA.”Applied Digital · RIVAL · from Applied Digital’s dossier
Weekly closes
- Insiders sold, 90 days: 139,957 sh · 11 filings, Form 4 · 2 Nov 2026
- Short interest: 76,629,611 sh · 5.16 days to cover, FINRA · settled 15 Oct 2026
- Insiders bought, 90 days: 6,000 sh · 1 filing, Form 4 · 15 Sept 2026
Who is buying
- Insiders sold, last 90 daysSEC Form 4 · newest 2 Nov 2026
- 11 filings · 139,957 shares
- Insiders bought, last 90 daysSEC Form 4 · newest 15 Sept 2026
- 1 filing · 6,000 shares
- Shares sold shortFINRA · settled 15 Oct 2026
- 76,629,611 shares
- Days to unwind the shortFINRA · settled 15 Oct 2026
- 5.16
The reported figures
| Period | As of | Revenue | Gross margin | Operating margin | Free cash flow | Capex | Cash | Net debt | Shares outstanding | Grading | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 ’24 | 31 Mar 2024 | $179M USD | 43.3% share of revenue | 30.8% share of revenue | -$9.7M USD | $31.9M USD | $98.1M USD | — | 177.8M shares | Filed · primary | 10-q-2024-q1 |
| Q2 ’24 | 30 Jun 2024 | $141M USD | 27.5% share of revenue | -64.3% share of revenue | -$1.9M USD | $3.1M USD | $96.1M USD | — | 258.2M shares | Filed · primary | 10-q-a-2025-q2 (restated Q2-2024 comparatives) + 10-q-2024-q2 (cash, cash flow) |
| Q3 ’24 | 30 Sept 2024 | $95.4M USD | -0.2% share of revenue | -43.2% share of revenue | -$25.5M USD | $31.2M USD | $253M USD | — | 279.3M shares | Filed · primary | 10-q-a-2025-q3 (restated Q3-2024 comparatives) + 10-q-2024-q3 (cash, cash flow) |
| Q4 ’24 | 31 Dec 2024 | $94.9M USD | 5.0% share of revenue | -68.9% share of revenue | -$15.0M USD | $28.8M USD | $836M USD | $286M USD | 294.1M shares | Filed · primary | 10-k-a-2024-q4 (restated FY2024) less 10-q-a-2025-q3 restated 9M-2024 |
| Q1 ’25 | 31 Mar 2025 | $79.5M USD | 10.3% share of revenue | -59.2% share of revenue | -$129M USD | $84.0M USD | $698M USD | $420M USD | 297.8M shares | Filed · primary | 10-q-2026-q1 (Q1-2025 comparatives) + 10-q-a-2025-q1 |
| Q2 ’25 | 30 Jun 2025 | $78.6M USD | 6.4% share of revenue | -33.4% share of revenue | -$87.3M USD | $121M USD | $581M USD | $505M USD | 305.4M shares | Filed · primary | 10-q-2026-q2 (Q2-2025 comparatives) + 10-q-a-2025-q2 |
| Q3 ’25 | 30 Sept 2025 | $81.1M USD | 4.8% share of revenue | -67.6% share of revenue | -$113M USD | $244M USD | $453M USD | $632M USD | 310.1M shares | Filed · primary | 10-q-a-2025-q3 |
| Q4 ’25 | 31 Dec 2025 | $79.8M USD | 26.0% share of revenue | — | -$122M USD | $279M USD | $311M USD | $774M USD | 315.3M shares | Filed · primary | 10-k-2025-q4 less 10-q-a-2025-q3 (9M 2025) |
| Q1 ’26 | 31 Mar 2026 | $115M USD | 26.1% share of revenue | — | -$139M USD | $389M USD | $1.0B USD | $1.1B USD | 317.9M shares | Filed · primary | 10-q-2026-q1 |
| Q2 ’26 | 30 Jun 2026 | $164M USD | 42.7% share of revenue | -47.8% share of revenue | -$584M USD | $565M USD | $1.8B USD | $2.6B USD | 321.3M shares | Filed · primary | 10-q-2026-q2 |
Core Scientific’s figures as the company reported them in its filings. Quarters are calendar quarters, so a company whose year ends in January shows each fiscal quarter under the calendar quarter it falls in. An empty slot is a quarter we hold no figure for.
Q2 ’26 · as of Jun 2026
Q2 ’26 · as of Jun 2026
A margin beyond ±100%, or on zero revenue, is left out as not meaningful.
Q2 ’26 · as of Jun 2026
Operating cash flow minus capital spending.
Q2 ’26 · as of Jun 2026
CashDebt
Q2 ’26 · as of Jun 2026
A rising count is dilution: each existing share owns less of the company.
What happened
Deals on the Ledger
| Announced | With | Type | Value | Source |
|---|---|---|---|---|
| 28 Jul 2026 | Site lease | undisclosedCore Scientific: more than $14B of potential base contracted revenue across ~530 MW at five sites. | Core Scientific 8-K, 2026-07-28 | |
| 7 Jul 2025 |
| Acquisition | $9BImplied total equity value of approximately $9.0B as of July 3, 2025 (0.1235 CRWV shares per CORZ share, fully diluted, CoreWeave 5-day VWAP). | CoreWeave 8-K Ex. 99.1, 2025-07-07 |
| 3 Jun 2024 |
| Site lease | $3.5BMore than $3.5B cumulative revenue over the initial 12-year terms (~$290M average annual revenue), per Core Scientific. | Core Scientific press release, 2024-06-03 |
Every Core Scientific deal on the Ledger — each one read against its source.
What Core Scientific has said about its capacity
1 statement · 1 campus · newest 27 Feb 2025
Happened
Stages the company says it reached, in the basis it used| Stated | Where | What it says | In its words | Source |
|---|---|---|---|---|
| 27 Feb 2025 | CoreWeave Denton | Contracted260 MW critical IT | “The 70 MW of expansion at the Denton site brings the full critical IT load to just over 260 MW.” | Regulatory filing, 27 Feb 2025 |
Megawatts are kept in the kind the source used and never added across kinds. A promised date is the latest day its words can bear, and only the company’s own later statements settle it.
Where we stand on Core Scientific
The old GPUs get cheap first: H100 rents fall as the new chips arrive, the newest hold
How our view changed
2 dossiers on Core Scientific since . The verdict has held each time.
The research around Core Scientific
Covered in the Knowledge Base
Datacenters & Digital Infrastructure
Company details
| Industry | Cloud Computing |
| Size | Public Company |
Others in datacenters
5 namesWhere Core Scientific sits against the other names we cover on this beat. Each line is that company’s verdict, not a summary of it.
MACOM
MTSIA quietly excellent RF-and-photonics compounder that the market has finally noticed
Cash $89.6M
Oklo
OKLOA $6.5B-EV option on a 2028 first-of-a-kind reactor with zero revenue, zero binding PPAs, and a Goldman-flagged ~$14B lifetime funding hole
Cash $1.6B · Runway ~1.9yr at this rate
Applied Optoelectronics
AAOIA real but sub-scale optical-transceiver share-gainer whose AI-data-center inflection is genuine
Cash $500M · Runway ~5.5yr at this rate
NuScale Power
SMRThe only NRC-approved SMR — but a pre-commercial story trading at 86x EV/sales while its entire $25B order book runs through ENTRA1, a 3-employee sing…
Cash $766M · Runway ~3.3yr at this rate
Vistra
VSTA merchant-power balance sheet wearing a regulated-utility's contracted growth
Cash $435M